Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Cirrhosis peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Cirrhosis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
1 profiles.
2006–2021 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Cirrhosis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00115947
PeptideScanner retained ClinicalTrials.gov record NCT00115947 at 2026-11-15T21:47:40.408Z. Its registry update date was 2006-03-09, and PeptideScanner's reviewed identity mapping was terlipressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 9, 2006
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00986817
PeptideScanner retained ClinicalTrials.gov record NCT00986817 at 2026-11-15T21:47:40.408Z. Its registry update date was 2015-06-15, and PeptideScanner's reviewed identity mapping was terlipressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 15, 2015
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03107091
PeptideScanner retained ClinicalTrials.gov record NCT03107091 at 2026-11-15T21:47:40.408Z. Its registry update date was 2021-07-13, and PeptideScanner's reviewed identity mapping was terlipressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- July 13, 2021
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Terlipressin · 2021-07-13
ClinicalTrials.gov record NCT03107091
Completed at the retained observation.
Open attributed record →Terlipressin · 2015-06-15
ClinicalTrials.gov record NCT00986817
Completed at the retained observation.
Open attributed record →Terlipressin · 2006-03-09
ClinicalTrials.gov record NCT00115947
Completed at the retained observation.
Open attributed record →